AstraZeneca hit by generic drugs and Crestor shortfall

LONDON (Reuters) - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries took a heavy toll, underscoring the turnaround challenge facing Britain's second-largest drugmaker.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news